4/A
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-032677
Chief Medical Officer acquired 170,354 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Smith Karen L. · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 1 in the form | +170,354 | 194,690 | D |
Loading xslF345X03/doc4a.xml…